183 related articles for article (PubMed ID: 27373496)
1. The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy.
Gul K; Mehmet K; Meryem A
Clin Nutr; 2017 Aug; 36(4):1022-1028. PubMed ID: 27373496
[TBL] [Abstract][Full Text] [Related]
2. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
Chang SC; Lai YC; Hung JC; Chang CY
Medicine (Baltimore); 2019 Feb; 98(8):e14463. PubMed ID: 30813149
[TBL] [Abstract][Full Text] [Related]
3. Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.
Topkan E; Parlak C; Topuk S; Pehlivan B
BMC Cancer; 2012 Oct; 12():502. PubMed ID: 23113946
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer.
Wiersma TG; Dahele M; Verbakel WF; van de Ven PM; de Haan PF; Smit EF; van Reij EJ; Slotman BJ; Senan S
Lung Cancer; 2013 Apr; 80(1):62-7. PubMed ID: 23357464
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
Topkan E; Yavuz MN; Onal C; Yavuz AA
Lung Cancer; 2009 Mar; 63(3):393-9. PubMed ID: 18691789
[TBL] [Abstract][Full Text] [Related]
6. Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.
Sanders KJ; Hendriks LE; Troost EG; Bootsma GP; Houben RM; Schols AM; Dingemans AM
J Thorac Oncol; 2016 Jun; 11(6):873-9. PubMed ID: 26940529
[TBL] [Abstract][Full Text] [Related]
7. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.
Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H
Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978
[TBL] [Abstract][Full Text] [Related]
8. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684
[TBL] [Abstract][Full Text] [Related]
9. Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients.
Gul K; Muge A; Taner A; Sehri E
Asian Pac J Cancer Prev; 2015; 16(1):53-8. PubMed ID: 25640390
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.
Lim HJ; Lee HY; Lee KS; Han J; Kwon OJ; Park K; Ahn YC; Kim BT; Shim YM
Cancer Chemother Pharmacol; 2015 Jan; 75(1):77-85. PubMed ID: 25374409
[TBL] [Abstract][Full Text] [Related]
11. Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
Ninomiya K; Ichihara E; Hotta K; Sone N; Murakami T; Harada D; Oze I; Kubo T; Tanaka H; Kuyama S; Kishino D; Bessho A; Harita S; Katsui K; Tanimoto M; Kiura K
Clin Lung Cancer; 2017 Mar; 18(2):245-249. PubMed ID: 27847247
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
[TBL] [Abstract][Full Text] [Related]
13. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
14. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.
Topkan E; Parlak C; Selek U
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):697-704. PubMed ID: 24035331
[TBL] [Abstract][Full Text] [Related]
15. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
[TBL] [Abstract][Full Text] [Related]
17. Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancer.
Kuroda Y; Sekine I; Sumi M; Sekii S; Takahashi K; Inaba K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Murakami N; Morota M; Mayahara H; Ito Y; Tamura T; Nemoto K; Itami J
Technol Cancer Res Treat; 2013 Aug; 12(4):333-9. PubMed ID: 23369154
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.
Nguyen QN; Ly NB; Komaki R; Levy LB; Gomez DR; Chang JY; Allen PK; Mehran RJ; Lu C; Gillin M; Liao Z; Cox JD
Radiother Oncol; 2015 Jun; 115(3):367-72. PubMed ID: 26028228
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
20. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
